Therapy News and Research

RSS

Quitting smoking found to be one of the toughest New Year's resolutions

Most New Year's resolutions fail. A study, from the United Kingdom's Royal Society of Public Health, found that that "quitting smoking is the most difficult resolution to keep.

30 Dec 2017

Blueberry extract can enhance effectiveness of cervical cancer treatment

According to the Centers for Disease Control and Prevention, approximately 12,000 women in the United States are diagnosed with cervical cancer each year.

29 Dec 2017

Gene therapy with CAR T-cells could create long-term immunity from HIV

Through gene therapy, researchers engineered blood-forming stem cells (hematopoietic stem/progenitor cells, or HSPCs) to carry chimeric antigen receptor (CAR) genes to make cells that can detect and destroy HIV-infected cells.

29 Dec 2017

Proteasome inhibitor treatment can lead to cardiovascular problems in multiple myeloma patients

The proteasome inhibitor carfilzomib has taken on an increasing role in the treatment of multiple myeloma, but new research from the Abramson Cancer Center of the University of Pennsylvania shows the therapy comes with the risk of cardiovascular problems in a higher than expected percentage of patients.

28 Dec 2017

Researchers reveal how tumor cells disrupt circadian rhythm to survive

Tumor cells use the unfolded protein response to alter circadian rhythm, which contributes to more tumor growth, Hollings Cancer Center researchers at the Medical University of South Carolina find.

28 Dec 2017

$Study uncovers genomic targets in refractory neuroblastoma$

Study uncovers genomic targets in refractory neuroblastoma

Neuroblastoma (NB) is the most common solid tumor found in children. It starts in some very early forms of nerve cells found in the embryo or fetus.

28 Dec 2017

Reduced activity of transcription factor plays key role in triggering pulmonary fibrosis

To date, the molecular basis of pulmonary fibrosis has been poorly understood. Scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim have now shown that reduced activity of the transcription factor FoxO3 plays a key role in the development of the disease.

26 Dec 2017

Novel GammaPod system receives FDA clearance to treat early stage breast cancer

The GammaPod - a first-of-its kind stereotactic radiotherapy system to treat early stage breast cancer - has received 510(k) clearance from the U.S. Food and Drug Administration, paving the way for the manufacturer to bring the system to market for the treatment of breast cancer patients.

26 Dec 2017

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Novartis announced today that the US Food and Drug Administration (FDA) approved the inclusion of Treatment-free Remission (TFR) data in the Tasigna® (nilotinib) US product label.

26 Dec 2017

Study finds role of ligands in allergic sensitization phase

Researchers from Universidad Politécnica de Madrid find direct evidence that the ligands, compounds carried by allergens, are actively involved in the allergic sensitization phase.

26 Dec 2017

International researchers find valuable clues for developing robust therapeutic agents against IBDs

Our immune system protects our bodies from numerous pathogenic microbes and toxins in the environment. The system comprises innate (non-specific) and adaptive (acquired) immunity.

26 Dec 2017

Novel radiotherapy system receives FDA clearance for treating early stage breast cancer

The GammaPod – a first-of-its kind stereotactic radiotherapy system to treat early stage breast cancer – has received 510(k) clearance from the U.S. Food and Drug Administration, paving the way for the manufacturer to bring the system to market for the treatment of breast cancer patients.

22 Dec 2017

Hormone therapy combination may improve metabolism without increasing risk of reproductive cancer

Treating ovariectomized mice with a combination of conjugated estrogens and the drug bazedoxifene triggers the expression of genes that improve metabolism and prevent weight gain - without stimulating the uterus and increasing risks of reproductive cancer, a new study suggests.

22 Dec 2017

Proton therapy center for treating cancer patients coming to Utah

A new cancer treatment technology is one step closer to Salt Lake City. Today Huntsman Cancer Institute at the University of Utah announced a plan to add a proton therapy center to its Cancer Hospital.

22 Dec 2017

Edixomed develops revolutionary technology for tackling antimicrobial resistance

New results announced at the recent Wounds UK conference and Eurobiofilms 2017 congress, have provided the latest evidence that Edixomed, a UK biotechnology company, has developed a revolutionary new technology for tackling the enormous public health challenge of antimicrobial resistance (AMR).

22 Dec 2017

Second edition of Open Accelerator program unveils winning Life Science start-ups

Zcube today announces the winners of the second edition of its Open Accelerator program aimed at Life Science start-ups and entirely supported by the Italian company: Zambon.

22 Dec 2017

Study finds new marker to detect fatal breast cancer

A new study conducted at the University College London, UK, found a new marker that has the capacity to help diagnose fatal breast cancer up to one year earlier than existing methods.

22 Dec 2017

Tumor growth traits can influence response to cancer drugs, study finds

Individual tumors respond differently to cancer drugs, if at all. Until now, it remained a mystery why tumors have different reactions to the exact same therapy. But a new study at the USC Viterbi School of Engineering finds that tumor growth properties can influence response to cancer drugs.

21 Dec 2017

Drugs alone may not improve chances of successful quitting among smokers, study suggests

Pharmaceutical interventions are routinely prescribed to help people quit smoking. However, a new study by University of California San Diego School of Medicine researchers suggests that, despite promising results in clinical trials, smoking cessation drugs alone may not be improving the chances of successful quitting among smokers in general.

21 Dec 2017

Study findings could lead to less expensive and more effective cancer treatments

The latest generation of cancer treatments spring from the discovery that the human immune system is able to beat the disease. Like Dorothy in "The Wizard of Oz," what research teams around the world have spent decades searching for was right in their own backyard all along.

20 Dec 2017

Therapy News and Research

Quitting smoking found to be one of the toughest New Year's resolutions

Blueberry extract can enhance effectiveness of cervical cancer treatment

Gene therapy with CAR T-cells could create long-term immunity from HIV

Proteasome inhibitor treatment can lead to cardiovascular problems in multiple myeloma patients

Researchers reveal how tumor cells disrupt circadian rhythm to survive

Study uncovers genomic targets in refractory neuroblastoma

Reduced activity of transcription factor plays key role in triggering pulmonary fibrosis

Novel GammaPod system receives FDA clearance to treat early stage breast cancer

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Study finds role of ligands in allergic sensitization phase

International researchers find valuable clues for developing robust therapeutic agents against IBDs

Novel radiotherapy system receives FDA clearance for treating early stage breast cancer

Hormone therapy combination may improve metabolism without increasing risk of reproductive cancer

Proton therapy center for treating cancer patients coming to Utah

Edixomed develops revolutionary technology for tackling antimicrobial resistance

Second edition of Open Accelerator program unveils winning Life Science start-ups

Study finds new marker to detect fatal breast cancer

Tumor growth traits can influence response to cancer drugs, study finds

Drugs alone may not improve chances of successful quitting among smokers, study suggests

Study findings could lead to less expensive and more effective cancer treatments

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News